Ignite Creation Date:
2025-12-24 @ 10:54 PM
Ignite Modification Date:
2026-01-03 @ 12:31 PM
Study NCT ID:
NCT03069469
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-18
First Post:
2017-02-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor
Sponsor:
Deciphera Pharmaceuticals, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-02-16
Start Date Type:
ACTUAL
Primary Completion Date:
2026-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-08
Completion Date Type:
ESTIMATED
First Submit Date:
2017-02-20
First Submit QC Date:
None
Study First Post Date:
2017-03-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-16
Last Update Post Date:
2025-12-18
Last Update Post Date Type:
ESTIMATED